|
Designated Public Office Holders who participated in the communication:
|
Shahad Khalladi,
Senior Policy Advisor
Minister's office,
Health Canada (HC)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health
|
Communications regarding the value assessment of new medicines by Canada's Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors.
|
|
Economic Development,
Industry,
Research and Development
|
Innovation, Science and Economic Development (ISED)'s Biomanufacturing and Life Sciences Strategy, pertaining to growth and development of the life sciences industry in Canada.
|
|
Health
|
The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors.
|
|
| |
|
Responsible Officer who filed this communication report:
|
RAMI FAYED
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
